Early-stage beta
· Errors & gaps may exist · Expanding: US · Nordics · EU
← All companies
/
Top lists
/
Boston Scientific
Boston Scientific
2018–2025 · Healthcare
2026-08-11
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
9 823
10 735
9 913
11 888
12 682
14 240
16 747
20 074
Operating profit (EBIT)
1 506
1 518
−80
1 199
1 649
2 343
2 603
3 613
Net income attributable to shareholders
1 671
4 700
−115
985
642
1 570
1 853
2 898
EBIT margin
15,3%
14,1%
−0,8%
10,1%
13,0%
16,5%
15,5%
18,0%
Gross margin
—
—
65,1%
68,8%
68,8%
69,5%
68,6%
69,0%
Operating cash flow
310
1 836
1 508
1 870
1 526
2 503
3 435
4 534
Free cash flow
−6
1 375
1 132
1 316
938
1 792
2 645
3 658
Cash
587
146
1 734
1 925
928
865
414
1 965
Interest-bearing debt
2 000
1 011
—
9 065
8 935
9 102
—
11 436
−5 000
0
5 000
10 000
15 000
20 000
25 000
−5,0%
0,0%
5,0%
10,0%
15,0%
20,0%
2018
2019
2020
2021
2022
2023
2024
2025
9 823
10 735
9 913
11 888
12 682
14 240
16 747
20 074
1 506
1 518
−80
1 199
1 649
2 343
2 603
3 613